2025-08-14 - Analysis Report
Okay, here's a report analyzing Albemarle Corp (ALB) based on the provided data.

## Albemarle Corp (ALB) Analysis

**Albemarle Corp (ALB) is a specialty chemicals company with leading positions in lithium, bromine specialties, and catalysts.**

### 1. Performance vs. S&P 500 (VOO)

*   **ALB Cumulative Return:** 21.74%
*   **VOO Cumulative Return:** 86.23%
*   **Absolute Divergence (ALB - VOO):** -63.6
*   **Relative Divergence:** 3.0 (This indicates ALB's performance is near the lower end of its historical divergence range compared to VOO.)

**Analysis:** ALB has significantly underperformed the S&P 500 (VOO) over the period analyzed. The relative divergence suggests this underperformance is near the worst-case scenario historically.

**Alpha, Beta Analysis:**

| Year       | CAGR   | MDD   | Alpha  | Beta | Cap(B) |
|------------|--------|-------|--------|------|--------|
| 2015-2017  | -4.0%  | 0.0%  | -6.0%  | 2.1  | 15.1   |
| 2016-2018  | -31.0% | 57.3% | -27.0% | -0.0 | 9.1    |
| 2017-2019  | -26.0% | 57.3% | -49.0% | -0.0 | 8.6    |
| 2018-2020  | 104.0% | 62.7% | 77.0%  | -0.0 | 17.4   |
| 2019-2021  | 214.0% | 62.7% | 165.0% | -0.1 | 27.5   |
| 2020-2022  | 187.0% | 75.6% | 181.0% | -0.0 | 25.5   |
| 2021-2023  | -32.0% | 77.5% | -52.0% | 0.5  | 17.0   |
| 2022-2024  | -145.0% | 77.5% | -172.0% | 0.9  | 10.1   |
| 2023-2025  | -240.0% | 77.5% | -291.0% | 0.5  | 9.6    |

**Analysis:**

*   **CAGR:** The company has seen highly variable performance over the periods analyzed, ranging from significant growth (e.g., 214% from 2019-2021) to substantial declines (e.g., -240% from 2023-2025). The recent negative CAGR values suggest a significant downturn in performance.
*   **MDD:** Maximum Drawdown (MDD) values are consistently high, indicating substantial risk and volatility. The MDD has increased over the periods, peaking at 77.5%, highlighting significant potential losses for investors during these times.
*   **Alpha:** Alpha, which measures the stock's performance relative to a benchmark, is predominantly negative, particularly in recent years. This suggests that Albemarle has underperformed its benchmark, likely due to company-specific issues rather than overall market trends.
*   **Beta:** Beta values vary, indicating fluctuating sensitivity to market movements. Some periods show negative betas (e.g., 2016-2018), suggesting the stock moved inversely to the market. More recent betas are positive (0.5 and 0.9), indicating a move towards positive market correlation but with high volatility.
*   **Cap(B):** Market capitalization has fluctuated over the years, peaking around $27.5B in 2019-2021 but declining significantly to $9.6B by 2023-2025. This decline reflects investor sentiment and company performance.

### 2. Recent Stock Price Movements

*   **Current Price:** $81.67
*   **Previous Close:** $77.98
*   **Change:** 4.73
*   **5-day Moving Average:** 77.19
*   **20-day Moving Average:** 75.049
*   **60-day Moving Average:** 66.5933

**Analysis:** The stock price has recently increased, closing at $81.67 with a significant jump of $4.73 from the previous close. The 5-day and 20-day moving averages are both below the current price, indicating a short-term upward trend. The 60-day moving average is significantly lower, suggesting a more sustained upward momentum recently.

### 3. Technical Indicators and Expected Return

*   **Market Risk Indicator (MRI):** 0.3234 (Low Risk)
*   **RSI:** 46.72 (Neutral)
*   **PPO:** 0.70 (Positive momentum)
*   **Hybrid Signal:** cash_1%_Buy 90% of cash (93 shares - Safe - MRI:0.32)
*   **Recent (20-day) Relative Divergence Change:** -0.1 (Short-term decline)
*   **Expected Return:** 4121.6% (Long-term, relative to S&P 500)

**Analysis:**

*   The **MRI** indicates a "Low Risk" environment, suggesting relatively stable market conditions.
*   The **RSI** is at 46.72, suggesting a neutral position, neither overbought nor oversold.
*   The **PPO** is positive (0.70), indicating potential upward momentum.
*   The **Hybrid Signal** suggests a 90% buy signal, which is considered a safe approach given the MRI of 0.32.
*   The negative change in recent relative divergence (-0.1) suggests a short-term decline compared to the S&P 500.
*   The high **Expected Return** (4121.6%) implies significant long-term potential outperformance compared to the S&P 500 if a buy-and-hold strategy is followed.

The significant price change from the previous close (4.73) suggests a potential catalyst influencing market sentiment. This rapid movement should be monitored for sustainability.

### 4. Recent News & Significant Events

*   **[2025-08-13]:** Major business developments, regulatory changes, or market events.
*   **[2025-08-14]:** Analysts discussing performance and outlook in the context of industry trends and global economic factors.
*   **[2025-08-11]:** Notable stock volatility due to recent news, earnings reports, or executive actions.
*   **[2025-08-10]:** Market experts highlight risks and opportunities, advising investors to monitor recent news and company announcements.

**Analysis:** The news indicates the company is experiencing notable volatility and is subject to significant market attention. Monitoring these events is crucial for understanding the underlying drivers of price movements.

### 5. Recent Earnings Analysis:

| 날짜       | EPS    | 매출       |
|------------|--------|------------|
| 2025-08-04 | -0.16  | 1.33 B$    |
| 2025-04-30 | 0      | 1.08 B$    |
| 2024-11-06 | -9.45  | 1.35 B$    |
| 2024-07-31 | -1.96  | 1.43 B$    |
| 2025-08-04 | -1.96  | 1.43 B$    |

**Analysis:** The recent earnings data reveals a mixed picture. EPS has been negative for most quarters, indicating unprofitability, with significant losses reported in 2024-11-06. While revenues have fluctuated, the trend indicates some decline.

### 6. Financial Information:

Revenue and Profitability:

| Quarter    | Revenue    | Profit Margin |
|------------|------------|---------------|
| 2025-06-30 | $1.33B     | 14.80%        |
| 2025-03-31 | $1.08B     | 14.51%        |
| 2024-12-31 | $1.23B     | 11.22%        |
| 2024-09-30 | $1.35B     | -7.68%        |
| 2024-06-30 | $1.43B     | -0.74%        |

Capital and Profitability:

| Quarter    | Equity     | ROE      |
|------------|------------|----------|
| 2025-06-30 | $10.24B    | 0.22%    |
| 2025-03-31 | $10.03B    | 0.41%    |
| 2024-12-31 | $9.96B     | 0.76%    |
| 2024-09-30 | $10.24B    | -10.44%  |
| 2024-06-30 | $11.22B    | -1.68%   |

**Analysis:** The financial data indicates fluctuating revenues and profit margins, with recent improvements in profitability but significant losses in earlier quarters. ROE has been low or negative, reflecting the company's struggles with profitability and capital efficiency.

### 7. Overall Analysis and Conclusion

Albemarle Corp (ALB) presents a complex investment picture.

*   **Performance:**  The stock has significantly underperformed the S&P 500, with substantial historical volatility.
*   **Financials:**  Recent revenue and profit margins have shown fluctuations, but the overall trend indicates some instability. EPS has been negative, and ROE has been low.
*   **Technicals:**  Recent stock price movements suggest a short-term upward trend, with positive signals from PPO. The MRI indicates a low-risk environment.
*   **News:** Recent news suggests the company is experiencing notable volatility and is subject to significant market attention.

**Recommendation:** While the long-term expected return is high, the current financial metrics and historical performance suggest significant risks. Investors should carefully consider the recent negative earnings, high volatility, and underperformance relative to the S&P 500. Monitoring the news and company announcements will be critical for assessing the company's future prospects. The buy signal suggested by the hybrid signal should be viewed cautiously, considering the mixed financial and performance data.
